Verified peer comparison
Chain Bridge Bancorp, Inc. Class A Common Stock vs Spero Therapeutics, Inc. Financial Comparison
Chain Bridge Bancorp, Inc. Class A Common Stock versus Spero Therapeutics, Inc.…
Direct answer
Chain Bridge Bancorp, Inc. Class A Common Stock and Spero Therapeutics, Inc. are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Chain Bridge Bancorp, Inc. Class A Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Chain Bridge Bancorp, Inc. Class A Common Stock Revenue
- 59,392,000 USD
- Spero Therapeutics, Inc. Revenue
- 59,619,000 USD
- Chain Bridge Bancorp, Inc. Class A Common Stock Operating income
- 25,397,000 USD
- Spero Therapeutics, Inc. Operating income
- -24,000 USD